Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation is a research paper published in Transplantation and Cellular Therapy (2021). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Health Resources and Services Administration
Grant: N00014-20-1-2705
Health Resources and Services Administration
Grant: N00014-20-1-2832
National Institute of Allergy and Infectious Diseases
Grant: HHSH250201700006C
National Institute of Allergy and Infectious Diseases
Grant: OT3HL147741
National Institute of Allergy and Infectious Diseases
Grant: U01HL128568
National Institute of Allergy and Infectious Diseases
Grant: U24HL138660
U.S. Public Health Service
Grant: U24CA076518
Office of Naval Research
Grant: P01CA111412
Office of Naval Research
Grant: R01AI128775
Office of Naval Research
Grant: R01CA152108
Office of Naval Research
Grant: R01CA215134
Office of Naval Research
Grant: R01CA218285
Office of Naval Research
Grant: R01CA231141
Office of Naval Research
Grant: R01HL126589
Office of Naval Research
Grant: R01HL129472
Office of Naval Research
Grant: R01HL130388
Office of Naval Research
Grant: R01HL131731
Office of Naval Research
Grant: U01AI069197
Office of Naval Research
Grant: U01AI126612
Office of Naval Research
Grant: UG1HL06924
NHLBI NIH HHS
Grant: K23 HL141445
NCI NIH HHS
Grant: P30 CA008748
NCATS NIH HHS
Grant: KL2 TR003143
National Institutes of Health
Grant: 5R01HL131731-05
Identifying Predictors of Poor Health-Related Quality-of-life among Pediatric Hematopoietic Stem Cell Donors
National Institutes of Health
Grant: 5R01AI128775-11
Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data
National Institutes of Health
Grant: 5R01HL129472-05
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
National Institutes of Health
Grant: 5R01HL126589-02
Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients
National Institutes of Health
Grant: 3OT3HL147741-01S1
Cure Sickle Cell
Jazz Pharmaceuticals
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U01AI069197-15
Hematopoietic Stem Cell and Cord Blood Transplantation
National Institutes of Health
Grant: 5R01CA152108-04
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
National Institutes of Health
Grant: 6R01CA218285-06
Immuno and Epigenetics of Hematopoietic Cell Transplantation
National Institutes of Health
Grant: 5P01CA111412-04
NK Cells, Their Receptors and Unrelated Donor Transplant
National Institutes of Health
Grant: 1R01CA215134-01
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
National Institutes of Health
Grant: 2U24CA076518-16
A Data Resource for Analyzing Blood and Marrow Transplants
National Institutes of Health
Grant: 1U24HL138660-01
Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center
National Institutes of Health
Grant: 5KL2TR003143-04
Institutional Career Development Core (KL2)
National Institutes of Health
Grant: 1R01HL130388-01
Improving the Availability of Younger Unrelated Hematopoietic Stem Cell Donors
Sanofi
Takeda Pharmaceuticals U.S.A.
Janssen Pharmaceuticals
National Institutes of Health
CareDx
Daiichi-Sankyo
Jazz Pharmaceuticals
U.S. Navy
Celgene
Kiadis Pharma
National Heart, Lung, and Blood Institute
Pfizer
Government of South Australia
National Cancer Institute
Angiocrine Bioscience
Astellas Pharma US
Biomedical Advanced Research and Development Authority
Boston Children's Hospital
Bristol-Myers Squibb
CSL Behring
U.S. Department of Defense
Amgen
Merck Sharp and Dohme
FWCI
1.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals